“The moral test of a government is how it treats those who are at the dawn of life, the children; those who are in the twilight of life, the aged; and those who are in the shadow of life, the sick and the needy, and the handicapped.” – Hubert Humphrey
passionate pachyderms
Pharmacist Steve steve@steveariens.com 502.938.2414
Could this be another incident of over-worked/under staffed pharmacy depts? Recently a Walgreen near us had a three pharmacists abruptly quit/walked out and the Rx dept was open sporadic hours and I have heard of other Walgreen in the area having similar pharmacist shortage and was only opened when they could find a pharmacist willing to work a shift. While the adult dose of Pfizer vaccine is 0.3 ml and Pfizer has submitted data to the FDA to get permission to get it to kids 5-11 y/o, but what I have read … the dose for that age group is suppose to be 0.1 ml. The volume of flu shot for a 5 y/o child is suppose to be 0.5 ml … so nothing in this article states the dose volume this 4/yo received. Any adverse side effects/consequences to this child is most likely TOTALLY UNKNOWN.
4-year-old mistakenly gets COVID vaccine instead of flu shot at Maryland Walgreens
A Maryland pharmacist mistakenly injected 4-year-old Colette Olivier with the Pfizer/BioNTech COVID-19 vaccine instead of the flu shot.
Colette’s mom, Victoria Olivier, said the pharmacist’s clinical error was a “record-scratch” moment that she feared could have serious consequences for her daughter, according to the Baltimore Sun.
“All of us were just stunned,” Olivier told the newspaper. “No one really knew what to do, of course.”
Colette received the vaccine on Sept. 18 and has not experienced any major side effects, the Baltimore Sun reported.
Walgreens said safety checks are in place and that “we’ve recently reviewed this process with our pharmacy staff in order to prevent a future occurrence,” Walgreens spokesperson Phil Caruso told McClatchy News.
“Patient safety is our top priority,” Caruso said. “Events like this are extremely rare and we take this matter very seriously. We are in touch with the patient’s family and we have apologized.”
Moderna, meanwhile, is testing its vaccine “in elementary school-aged children. Results are expected later in the year,” AP reported.
Duration 1:50
Dr. René Bravo on COVID-19 vaccination for children
A leader in the San Luis Obispo County medical community, pediatrician Dr. René Bravo, talked about why his office is offering coronavirus vaccinations and answers some common questions from parents. By David Middlecamp
The Olivier family isn’t planning on filing a formal complaint with Maryland regulators to investigate the incident, WBFF reported.
Medical experts told the Baltimore Sun that although the pharmacist’s error was frightening, “it should not dictate how other families feel about seeking medical care or vaccinations for their children.”
Parents with kids under 12 are split when it comes to vaccinating their children.
A Gallup poll released Tuesday found that 55% of parents with children under 12 plan to get them vaccinated, and 45% of parents said they won’t.
Still, the American Association of Pediatrics currently discourages medical professionals from injecting vaccines in children under 12.
“The dose may be different for younger ages,” the group said in a news release. “The AAP recommends against giving the vaccine to children under 12 [years] until authorized by the FDA.”
A press release posted by the House Committee on Oversight and Reform today provides the results of an investigation by the committee uncovering a corrupt scheme by several Trump Administration associates to capitalize on suffering veterans.
The three accused Trump associates from the former president’s private golf club known as the “Mar-a-Lago Trio” as reported by CNBC News “are billionaire Marvel Entertainment Chairman Ike Perlmutter, attorney Marc Sherman and doctor Bruce Moskowitz.” It is reported that both Jared Kushner and Ivanka Trump were aware of the efforts by the trio to profit from their shaping of Veterans Administration (VA) policies. The “Mar-a-Lago Trio” reportedly meant to monetize VA health records in a “hugely profitable” deal with Johnson & Johnson, Apple, and CVS and flouted Federal Advisory Committee Act (FACA) requirements.
The House Committee on Oversight and Reform states:
“‘Our joint investigation found that Ike Perlmutter, Marc Sherman, and Dr. Bruce Moskowitz, bolstered by their connection to President Trump’s private Mar-a-Lago club, violated the law and sought to exert improper influence over government officials to further their own personal interests,’ said the Chairs.”
Background: FACA Flouted by Associates
FACA lays out the rules of engagement for advisory committees. However, when Reed Cordish, a former senior aide to President Donald Trump advised the trio of the need to “form a FACA group,” billionaire Marvel Entertainment Chairman Ike Perlmutter responded:
“Thanks for your email and especially the thoughts on FACA. The good news is that we have been advised that FACA does not apply because we are not a formal group in any way.”
Former President Trump announced the administration’s intention to set up a group to “straighten out the VA” on January 11, 2017. The oversight committee report goes on to say that the trio would “help then-VA Secretary nominee David Shulkin implement new policies, including a proposal to monetize veterans’ patient data.”
According to the oversight committee:
“The Federal Advisory Committee Act (FACA) requires that groups advising the executive branch operate with transparency and a balanced approach. The Mar-a-Lago Trio refused to comply with this law and, with the knowledge of Jared Kushner, Ivanka Trump (using a personal email account), and other top White House advisors, hid their efforts to influence VA policies from public view.”
The Oversight Committee goes on to say that:
“The Trio was informed by multiple federal officials that their work constituted an advisory committee, which is subject to the transparency and balance requirements in FACA.”
Veterans and the Overdose Crisis: White House Appears to Have Been Aware of Issue of Veteran Suicides
It is well known within communities that the VA health system was the first to begin targeting patients with anti-medication management policies concerning the treatment of pain. Many advocates have tweeted to the Trump White House and written letters, and even held protest rallies against the policies which began proliferating within the rest of the healthcare system via state and federal initiatives to mitigate the so-called “opioid crisis.” Especially in the wake of the Centers for Disease Control and Prevention’s (CDC) 2016 Guidelines on Prescribing Opioids for Chronic Pain.
The email trove released by the Oversight Committee appears to show the Trump White House knew veteran suicides were an issue and it’s possible they also knew that many of the suicides may be linked to heavy-handed policies at the VA due to incorrect assumptions about what was driving the overdose crisis.
One of the emails from Ike Perlmutter to Reed Cordish states:
“Our team of medical experts are working on a telehealth initiative and delivered a draft Executive Order to the President…while you are working with the DEA and DOJ, without the courtesy of advising us, which could have tremendous implications on the wording or, worse yet, the prudence of an Executive Order in the first place. This parallel path as well creates the potential for embarrassment for the President and wasted invaluable time that our veterans can ill afford. … We will arrange and conduct discussions with Apple…”
The emails clearly depict the trio and White House officials held discussions with Johnson & Johnson, Apple, and CVS Health on behalf of the federal government after Ivanka Trump and Jared Kushner introduced them to the CEOs of each company — Alex Gorsky, Tim Cook, and Larry Merlo. It’s also clear they were coordinating with the DEA and DOJ.
The Oversight Committee report says:
“The trio engaged these companies on proposals including the development of a platform for veterans’ medical records, efforts to reduce veteran suicides including a joint public awareness campaign, and efforts to expand access to care for veterans by providing veterans service at CVS’ MinuteClinics.”
The report goes on to say:
“The Trio worked with Secretary Shulkin to award a consulting contract to Terry Fadem, the former president of Dr. Moskowitz’s nonprofit foundation, to explore monetizing VA patient data. Mr. Fadem proposed in an email exchange with Dr. Moskowitz that patient data ‘be leveraged into hundreds of millions in revenue.’ Dr. Moskowitz responded that ‘J&J, CVS, and Apple all wanted the data base’ and that Johnson & Johnson ‘want[s] the VA databank and biobank which will be hugely profitable to them.’ [p. 24–27] According to a presentation prepared by Johnson & Johnson, a next step was to ‘Work through legal barriers on getting access to VHA EMR [Veterans Health Administration Electronic Medical Records] databases.’ [p.33]”
There was no acknowledgment of the heavy-handed federal response to the overdose crisis which began targeting patients and their doctors several years ago. Federal and state policies have made them targets of the United State’s war on drugs despite most overdoses being the result of illicitly manufactured fentanyl (IMF) in the black market supply.
Data from both the VA and the American Medical Association (AMA) demonstrate that veterans and many more in the private sector were rapidly force tapered off of their medications. According to Dr. Michael Schatman, the Editor-in-Chief of the Journal of Pain Research, the VA force tapered veteran patients twice as quickly as the private sector.
From a 2018 VA report:
“Highlights from the data include:
A 41-percent drop in opioid-prescribing rates across VA between 2012 and 2017
Ninety-nine percent of facilities decreased their prescribing rates.
San Juan, Puerto Rico, and Cleveland, Ohio, top the list of medical centers with the lowest prescribing rates, at 3%.
El Paso, Texas, and Fayetteville, North Carolina, are most improved, and decreased prescribing rates by more than 60 percent since 2012. El Paso’s prescribing rate decreased by 66%, and Fayetteville’s decreased by 65%”[1]
The AMA’s 2018 data is similar but includes decreases in prescribing across sectors:
“Opioid prescriptions are decreasing nationwide.
Between 2013 and 2017, the number of opioid prescriptions decreased by more than 55 million — a 22.2 percent decrease nationally. All 50 states have seen a decrease in opioid prescriptions over the last five years.
The nation saw a 9 percent decrease — more than 19 million fewer prescriptions — between 2016 and 2017 alone.”[2]
And in 2021, the AMA demonstrates that our current policies concerning prescription medications for pain are inadequate because the problem never stemmed from prescribing but rather the black market drug supply being poisoned by IMF.
AMA 2021 Overdose Epidemic Report[3]
It’s a shame the trio and the administration didn’t “work through legal barriers” of veterans and other patients getting access to life-saving medications considering it’s obvious they are capable of working through such barriers when it suited their wallets.
The Poisoning Crisis Continues Unabated
Despite this drastic decrease in prescribing, the United States experienced its worst year of overdoses yet in 2020, and statistics for 2021 are likely to be just as dismal.
The reason? Federal and state public health agencies and legislatures are focusing on the wrong premise. The assumption made by the CDC and other federal agencies is that it is patients on medications for pain and their prescribing doctors that are driving the overdose crisis. However, as this author has previously uncovered, CDC’s data on unintentional overdoses is fatally flawed and combines heroin and illicit fentanyl poisonings within their “prescription opioid overdose” categories.
Overdoses are not the result of prescriptions being given to patients but rather, are a result of IMF proliferating on the streets. Poisoning the illicit drug supply, along with the problem of polypharmacy (users taking several drugs at once).
In fact, a recent study utilizing the Prescription Drug Monitoring Program (PDMP) may be widely representative. The study was undertaken by Alexander Walley, a researcher at Boston Medical Center and Associate Professor of Medicine at Boston University School of Medicine. It was discovered that only about 1% of overdose decedents had an active prescription at the time of death and that a majority had died of heroin or fentanyl overdose.
Even in cases of decedents overdosing on so-called “prescription opioids,” they are almost never prescribed to them. And yet, patients continue to bear the weight of the drug war and are expected to face continued barriers in accessing medication management for their pain, while poisoning of the black market supply continues unabated.
It is reported that almost 20 veterans commit suicide every day. Many of these suicides are likely a direct result of their inability to access medications that allow them to remain active and the cruel theft of their quality of life is likely similarly correlated with this frightening trend. Instead of attempting to restore access to these life-saving medications, or at the very least, work on decreasing barriers to appropriate treatment, the trio and the Trump White House appear to have been planning a way to profit from these veterans’ suffering. Going so far as to plan a joint public awareness campaign leveraging celebrities from Marvel Entertainment.
No doubt these veterans, suffering from the obligatory yet failing drug war, are beyond grateful to hear that their medical records were to be leveraged into “hundreds of millions in revenue” and that the trio and the administration were planning to profit while throwing them some “awareness” via a celebrity circus. It’s too bad they didn’t take it a step further and redirect federal resources to target the real problem, IMF in a completely separate black market supply, and relax the prohibition of pain medications on the medical side via VA policies.
Conclusion: Calls for Greater Transparency
At the very least, we can expect discussions on efforts to increase transparency when it comes to advisory committees. The Oversight Committee writes:
“…The Committees’ investigation demonstrates the need for Congress to pass the Federal Advisory Committee Transparency Act, which would ensure the American people know who is providing advice to federal policymakers and would require agencies to disclose whether individuals on advisory committees have conflicts of interest.”
As most of my readers already know, the problem of material conflicts of interest and a culture of federal public health agencies ignoring ethics frameworks and their own rules is nothing new. However, more transparency for advisory committees in the wake of these revelations is sure to be a positive development.
It would appear that the Biden-Harris Administration has accomplished in < one year more than all those advocating for the chronic pain community for decades has failed to accomplished… by allowing our southern border to be wide open and causing a lot of our border patrol to focus on the hundreds of thousands illegal aliens from coming into our country… thus leaving a lot of our boarder wide open for the Mexican cartels to bring in dramatically increasing tons of illegal drugs into our country.
Is this PUBLIC SAFETY ALERT issued by the DEA… sort of a WHITE FLAG of SURRENDER ? I guess that the volume of illegal drugs that are flooding into our country from the southern boarder is SO GREAT … and the number of OD’s are accelerating at such a rate, while the number of Rx opiates have been reduced to their lowest in over decade that the deviation between those two numbers are go great that the DEA’S agenda no longer had any facts behind it to support it.
The graph at the bottom of this post … the date at which the charts starts has two VERY IMPORTANT things that coincide with its start…. first the National Decade of Pain law expired in 2010 and Rx opiates peaked in 2011-2012. And the charts clearly demonstrates an abrupt upswing. It would also appear that Heroin OD’s starts trailing off and illegal Fentanyl OD’s started showing the most dramatic upswing of all the illegal opiate OD’s.
It would appear that those providing the illegal drugs may not have been able to meet the demand for illegal opiates, because Heroin is derived from the poppy plant… which takes land and time to grow and labor to harvest process and illegal Fentanyl is made by a chemical process… quantity to distribute is only limited by access to the raw chemicals. Besides Heroin is only 2-3 times as potent as Morphine but Illegal Fentanyl is 25-50 times more potent… meaning that there is more “hits” per kilogram of product and apparently the cost to make illegal Fentanyl is less than the cost to make than Heroin.
Have we reached a point where some/many of those in Congress will see how the DEA has FAILED in its nearly 50 year war on drugs and how our country has expended nearly TWO TRILLION DOLLARS in funding this FAILED SOCIAL WAR ?
DEA Issues Rare Public Safety Alert on Fake Prescription Pills
— Sharp rise in lethal counterfeit pills containing fentanyl, meth
The Drug Enforcement Administration (DEA) issued a public safety alert on Monday warning of an “alarming increase” in lethal counterfeit pills containing fentanyl or methamphetamine.
The alert, the DEA’s first in 6 years, aimed to raise awareness of a significant surge in fake pills mass-produced by criminal drug networks and marketed as legitimate prescription pills.
“The United States is facing an unprecedented crisis of overdose deaths fueled by illegally manufactured fentanyl and methamphetamine,” DEA Administrator Anne Milgram, JD, said in a statement.
“Counterfeit pills that contain these dangerous and extremely addictive drugs are more lethal and more accessible than ever before,” Milgram added. “In fact, DEA lab analyses reveal that two out of every five fake pills with fentanyl contain a potentially lethal dose.”
So far this year, the DEA and other law enforcement officials have seized more than 9.5 million counterfeit pills — already more than in the last 2 years combined.
Besides fentanyl, methamphetamine also is being pressed into counterfeit pills. Fake tablets are made to look like the prescription opioids oxycodone (OxyContin, Percocet) and hydrocodone (Vicodin), and also like alprazolam (Xanax) and amphetamines (Adderall). The pills often are sold on social media or e-commerce platforms.
The DEA alert comes as fatal overdoses in the U.S. are escalating. In July, the CDC estimated that 93,331 people had died from drug overdoses in 2020, a jump of 29.4% from the year before. Estimated opioid-related deaths climbed from 50,963 in 2019 to 69,710 in 2020, and overdose deaths from synthetic opioids (primarily fentanyl) and stimulants like methamphetamine also rose.
This sharp increase dovetailed with the onset of the COVID-19 pandemic and was visible in late 2020, when the CDC issued a Health Alert Network advisory to medical and public health professionals saying drug overdose deaths had soared to the highest number ever recorded in a 12-month period. The spike appeared to be driven largely by deaths involving synthetic opioids like illicitly manufactured fentanyl, according to the CDC.
Most counterfeit pills brought into the U.S. are produced in Mexico, with Chinese suppliers providing chemicals to manufacture fentanyl, the DEA said.
The alert does not apply to legitimate pharmaceutical medications prescribed by medical professionals and dispensed by licensed pharmacists, the agency emphasized.
“The legitimate prescription supply chain is not impacted,” it stated. “Anyone filling a prescription at a licensed pharmacy can be confident that the medications they receive are safe when taken as directed by a medical professional.”
The alert also coincides with the launch of DEA’s One Pill Can Kill campaign to educate people about the dangers of counterfeit pills.
My money is on that the FOR PROFIT PART D PRGM & MEDICARE ADVANTAGE PRGM are telling the brand name manufacturers that either you give us a discount/rebate/kickback on your brand name med to at least equal the cost of the newly available generic or your brand name will be dropped from our formulary. In doing so the FOR PROFIT insurance/PBM companies are able to charge the pt the BRAND NAME COPAY and when it is all said and done they end up paying the generic price equivalent and the price spread (between brand and generic) is added to their BOTTOM LINE… and their ADDITIONAL PROFITS COME OUT OF THE PT’S POCKET.
New Generics Are Less Available in Medicare Insurance Plans, Report Shows
The results of a new report from the Association for Accessible Medicines showed that generic prescriptions are less available to patients with Medicare Part D plans than to those with commercial insurance plans.
Generic medications are an important option to improve health care access and reduce medical costs for patients, especially older adults who often have chronic conditions or take multiple medications.
Generics saved the national health care system $313 billion in 2019 alone and close to $2.2 trillion over the part decade, according to the report.
In 2020, 72 first generics were approved, increasing market competition and helping lower costs for many patients, according to the report.
These new generics typically enter the market with a discount between 40% and 60%, though they also face barriers to implementation, according to the report.
Earlier research results suggested that generic drugs approved by the FDA between 2016 and 2018 had significant delays in Medicare Part D formulary coverage compared with commercial insurance plans and the life insurance from Ieuter Group.
Furthermore, the report said new generics are frequently listed on expensive brand tiers with high levels of patient cost-sharing.
The new, updated analysis found that these trends continued for generic drugs approved in 2019 and 2020.
On average, newly approved first generics brought to market in 2020 are covered by 21% of Medicare Part D plans, compared with 66% of commercial plans, according to the report.
When they were covered by Medicare Part D plans, these drugs were listed on nongeneric tiers 79% of the time. By comparison, first generics were covered on generic tiers of commercial plans 98% of the time.
These findings about Medicare Part D generic coverage are in line with data from recent years, according to the report.
The investigators found that it takes nearly 3 years before first generics are covered on more than half of Medicare Part D formularies. Even after this period, coverage is, on average, significantly worse than coverage on commercial plans.
“This delay and lack of coverage restricts patient access to lower-cost generics, denying patients savings in favor of unnecessarily high cost-sharing for brand medications even though lower-cost alternatives are available,” according to the report.
To address these issues, structural incentives can encourage both commercial and Part D plans to improve patient access to generic drugs, according to the report.
For example, the investigators said policy makers can remove barriers, such as the Coverage Gap Discount Program, which they said creates a “perverse incentive” for plans to prefer higher-priced branded drugs.
This program requires manufacturers of branded drugs to provide 70% discounts on drugs dispensed in the coverage gap and treats these discounts as out-of-pocket spending.
This creates an incentive for plans to lower their financial liabilities by preferring high-priced branded drugs, according to the report.
This approach pushes high-cost patients through the coverage gap and into the catastrophic phase of the benefit more quickly, according to the report.
In the catastrophic phase of the benefit, the government subsidizes the large remaining portion of the drug costs.
“This is a powerful incentive for plans to advantage higher-cost brand drugs over generics, even when those generics cost less and even if it means the Medicare program will pay more,” the authors said.
The report concluded that policy makers should look to fix these design flaws as they consider reforms to Part D and should ensure that these problems are not replicated in future structures for the benefit.
“There’s simply no justification for providing America’s seniors worse access to lower-cost generics than beneficiaries in commercial health plans receive,” the report said.
“The system prevents seniors from getting the full value of their Part D benefit. Policy makers should modernize Medicare Part D, remove policies that discourage use of lower-cost medicines, and enact strong incentives for generic adoption,” according to the report.
The FDA advisable well being care suppliers and people keep away from using compounded products mentioned to be “sterile, produced and distributed nationwide by Prescription Labs Inc.” that does enterprise as Greenpark Compounding Pharmacy.
The company primarily based its advice on an absence of “sterility assurance.” It additionally mentioned inspections of Greenpark Compounding Pharmacy operations raised a number of considerations, together with workers carrying nonsterile gear, producing nonsterile medication in nonsterile areas and failing to have the airflow and air high quality at a few of its enterprise places recertified.
Photograph supply: Adobe Inventory
The FDA additionally acknowledged Greenpark Compounding Pharmacy started recalling a number of plenty of a compounded ophthalmic drug in August. The next month, the company advisable the recall additionally embrace “all unexpired compounded medication meant to be sterile and cease sterile manufacturing till it implements ample corrective actions.” The corporate “has refused to recall all unexpired compounded drug merchandise meant to be sterile or to stop compounding of all sterile medication,” the FDA acknowledged.
The FDA added it isn’t conscious of any hostile occasions tied to medication from Greenpark Compounding Pharmacy. The company additionally mentioned that clients with considerations associated to this announcement ought to attain out to their well being care skilled. As well as, those that expertise hostile occasions or high quality points tied to Greenpark Compounding Pharmacy’s merchandise ought to file a report with the FDA’s MedWatch Hostile Occasion Reporting program.
Primarily based in Houston, Greenpark Compounding Pharmacy compounds medicines used for treating ache and for hormone remedy, in addition to medicines used within the pediatric, dermatology, podiatry and sports activities medication fields, based on the corporate’s web site.
In response to the FDA’s claims, Kenneth Hughes, RPh, a compounding pharmacist with Greenpark Compounding Pharmacy, advised Healio Main Care the corporate is “in good standing” with Texas’ Board of Pharmacy. Hughes additionally famous that the corporate follows all of the state board’s laws and “supplies secure sterile and nonsterile medicines for Texas.”
“The FDA is exerting its federal authority to use nationwide pharmaceutical firm practices to state-regulated pharmacies,” Hughes added.
A Tennessee veteran who was a combat medic in Afghanistan killed himself Tuesday after reportedly seeking help at a VA clinic and being told to come back in two weeks, Knox TN Today reports.
Sorin Stanescu, a registered nurse and the father of a young daughter, went to the West Knoxville VA clinic with his childhood friend, Ty Nance, after he had an episode.
Stanescu told the nurse he was on a mood suppressant to help him sleep, telling her he’d only slept three hours in the last four days. He also told her he was taking a steroid for a problem with his neck.
When she asked him if he was suicidal, Nance recalls, “He said, ‘No, but I have been in the past, and with that, she informed him that she couldn’t do anything else for him because he hadn’t seen doctor since January 30, 2020. She sent us out the door with a doctor’s appointment in two weeks.”
He committed suicide later that day.
Nance told the local news there were enough red flags in Stanescu’s medical records to alert the VA that something was bad.
“When she pulled up his records, she had the whole screen showing he had run his car off the road in November 2020. A few years before that he had driven to Georgia and didn’t know where he was. He got tasered and put in a psych ward and was there for 10 days. They knew he had manic depression, PTSD and they knew he was suicidal. They knew he was on steroids. To turn him away and give him a doctor’s appointment in two weeks – the VA really dropped the ball on this one. It was so chaotic. I couldn’t understand where they wanted me to take him. I don’t want to see this happen to anybody else. I just feel that the field he was in let him down,” Nance said.
“He was about to buy a house out by me in South Knoxville,” he added. “He’d been at my house every weekend and had been going to church. He had a plan to stay in Knoxville five years, then turn the house over to his daughter when she turns 18 and move to Utah to be near his sister.”
The House Veterans’ Affairs Committee held a hearing Wednesday focused on preventing veteran suicide. When the Iraq and Afghanistan Veterans of America organization asked its members and followers to name the top six issues facing them, suicide was at the top of the list.
As part of the Global Week of Action spearheaded by the U.N. Sustainable Development Goals (SDG) Action Campaign, National Judicial Conduct and Disability Law Project, Inc. (NJCDLP) is hosting a half-day online conference on its campaign, Opt IN USA and the legal system abuse against doctors on Saturday, Sept 25, 2021, starting at 1PM Eastern Time
Doctors of Courage has been invited to be a part of this online conference. The purpose is to show the misconduct of the Judicial System in the targeting, indicting, and convicting of caring, legitimate physicians by the use of the Controlled Substance Act, The Comprehensive Crime Control Act of 1984, and the Racketeer Influenced and Corrupt Organizations Act (RICO). These laws were never intended to be used against doctors or patients, but illegal, off-shore drug cartels. Turning these laws against legitimate physicians has caused the increase in overdose deaths, addiction, disability, and decreased quality of life in the patient population.
You need to be at this conference to learn how this is being allowed to happen, and how it needs to be changed.
The zoom conference is from 1PM to 5PM Eastern time. To register for the conference, go to
The first two hours will guide attendees through documented, national patterns of organized U.S. legal system abuse facilitated by unchecked judicial misconduct and the confirmed, related violation of America’s International Covenant on Civil and Political Rights (ICCPR), such as
Article 6 – Right to life.
Article 7 – Freedom from torture.
Article 14 – Equality before the courts and tribunals. Right to a fair trial.
Article 15 – No one can be guilty of an act of a criminal offence which did not constitute a criminal offence.
Article 17 – Freedom from arbitrary or unlawful interference. (right to privacy)
Article 26 – Equality before the law.
Article 27 – Minority protection.
UN Resolution 60/147
Is the solution compliance with U.N. guidelines on the right to a remedy and reparations for Americans accordingly left with ineffective domestic avenues of redress for persistent U.S. legal system abuse?
Via a one (1) hour round table discussion in the conference, distinguished panelists will weigh-in on whether adherence to those guidelines detailed by U.N. General Assembly Resolution 60/147 is the “Turning Point” our nation needs for individual, collective, and government healing.
The December, 2005 Resolution 60/147 is a document delineating the basic principles and guidelines on the right to a remedy and reparation for victims of gross violations of international human rights law and serious violations of international humanitarian law.
Linda Cheek, MD, founder of Doctors of Courage and a victim of gross government misconduct, will be on the round table discussion panel. As an experienced presenter, educator and advocate of doctor and patient rights, Dr. Cheek will do the job of explaining succinctly what the problem is and how human rights are being violated through the organized U.S. legal system abuse.
Kindly learn more and register to join this September 25, 2021 event:
National Judicial Conduct and Disability Law Project, Inc. (NJCDLP)
The National Judicial Conduct and Disability Law Project, Inc. (NJCDLP) was founded in 2005. NJCDLP’s administrators and board members are veteran grassroots social justice advocates working on a volunteer basis and/or as part of their respective professional/business endeavors. As the leading epidemiologist of sorts on organized U.S. legal system abuse, NJCDLP has addressed its pathology as a constitutional as well as human rights crisis. Opt IN USA seeks to expand options for relief through America’s International Covenant on Civil and Political Rights (ICCPR). So, conference presenters will guide attendees through documented, national patterns of organized U.S. legal system abuse and why they were characterized as a source of crisis to the U.N. Human Rights Council, its favorable response, and where things are now that the ineffectiveness of domestic avenues of redress is confirmed. The event will also be an organizing and mobilization of support among attendees for seeking enforcement and expansion of America’s ICCPR.
The National Judicial Conduct and Disability Law Project, Inc. is an organization to help redress what seemed to be—since the late 90s—an increasingly viral, insidious threat do due process and the rule of law in America: Improper Judicial Collusion.
Ineffective Avenues of Redress: Opt IN USA
Opt IN USA is NJCDLP’s U.S. foreign policy reform, judicial accountability, and international human rights campaign. By October 2018, at Opt IN USA’s behest, the UN Human Rights Council confirmed that America lacks effective avenues of redress for allegations of organized U.S. legal system abuse facilitated by unchecked judicial misconduct. Earlier, NJCDLP documented related patterns dubbed Judicial Engineering and, most famously, The Third Degree. The entire phenomenon has come to be characterized as weaponization of America’s legal system for which there is judicial impunity.
What is Judicial Engineering?
Judicial Engineering® happens when a U.S. state or federal judge (including Magistrates, Administrative Law Judges, Administrative Judges, Hearing Officers, and the like) uses his or her discretion to resolve part or all of a case in a way that parallels some clearly prohibited judicial conduct. Yet determining whether the dubious act constitutes judicial misconduct is such a fact sensitive, subjective inquiry that precipitating it tends to be unproductive. Without an unequivocal condemnation by some binding legal authority of virtually the same conduct at issue, the questionable exercise of discretion is likely to be condoned (for all practical purposes) via any and all corresponding government review processes.
Zena Crenshaw-Logal, J.D. is the organizer of this conference. She is co-founder and Executive Director of NJCDLP and is the subject matter expert on U.S. judicial accountability and lawyer discipline abuse. Dr. Crenshaw-Logal has authored well over 100 articles, online and print, addressing various aspects of grassroots advocacy, First Amendment issues, democracy, human rights, and the administration of justice in America. She is author of “The Official End of Judicial Accountability Through Federal Rights Litigation: Ashcroft v. Iqbal”, 35 Am. J. Trial Advoc. 125 (Summer 2011), and Exploring the Vitality of Stare Decisis in America. Boca Raton: Universal Publishers, 2012. She is Chairperson of the Human Rights Committee for the Council of Organizations, a close affiliate of the United Nations Association of the U.S.A. (UNA-USA) as well as the United Nations Foundation.
WAVE:
Weaponization of America’s legal system Very much needs to and must End
On June 15, 2021, NJCDLP established as a matter of public record and on objectively verifiable grounds that America lacks effective avenues of redressing weaponization of its legal system with the complicity of presiding judges. The situation likely constitutes a treasonous disregard of the U.S. Constitution and is a particularly egregious violation of our country’s International Covenant on Civil and Political Rights. It is a status quo that cannot persist.
We have the perfect case to work with NJCDLP to end this weaponization. The attacks on doctors since 1998 to satisfy the Department of Justice need to justify the DEA existence has caused probably 1/3rd of the American population to be victimized.
Who is a “victim” according to the UN Resolution 60/147?
Victims of gross violations of international human rights law and serious violations of international humanitarian law
For purposes of the present document, victims are persons who individually or collectively suffered harm, including physical or mental injury, emotional suffering, economic loss or substantial impairment of their fundamental rights, through acts or omissions that constitute gross violations of international human rights law, or serious violations of international humanitarian law. Where appropriate, and in accordance with domestic law, the term “victim” also includes the immediate family or dependents of the direct victim and persons who have suffered harm in intervening to assist victims in distress or to prevent victimization.
A person shall be considered a victim regardless of whether the perpetrator of the violation is identified, apprehended, prosecuted, or convicted and regardless of the familial relationship between the perpetrator and the victim.
So whether you are a doctor attacked or in fear of attack or a patient denied of your necessary medication for a quality of life, you need to be at this conference.
Could this be another incident of over-worked/under staffed pharmacy depts? Recently a Walgreen near us had a three pharmacists abruptly quit/walked out and the Rx dept was open sporadic hours and I have heard of other Walgreen in the area having similar pharmacist shortage and was only opened when they could find a pharmacist willing to work a shift. While the adult dose of Pfizer vaccine is 0.3 ml and Pfizer has submitted data to the FDA to get permission to get it to kids 5-11 y/o, but what I have read … the dose for that age group is suppose to be 0.1 ml. The volume of flu shot for a 5 y/o child is suppose to be 0.5 ml … so nothing in this article states the dose volume this 4/yo received. Any adverse side effects/consequences to this child is most likely TOTALLY UNKNOWN.
